pancan1d
Research Spotlight
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit offers insight into the new NCCN guidelines, discusses the new ...
precisionmedicineonline2d
Perthera AI-Driven Predictor Enables Molecularly Guided Therapy for First-Line Pancreatic Cancer Treatment
The tool predicts which of two standard front-line chemotherapy options a patient with advanced pancreatic cancer is likely to benefit from.
Nature3d
Bespoke vaccines can elicit long-lived immune activity against pancreatic cancer
A multicentre randomized trial of bespoke RNA vaccines in pancreatic cancer (NCT05968326) is under way to further test this approach. • Cancers with few mutations, such as pancreatic cancer ...
Cure Today10d
Explaining KRAS Mutations For Patients With Colorectal Cancer
Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.
Metastatic Pancreatic Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
The leading Metastatic Pancreatic Cancer Companies such as Xencor, MEI Pharma, Celldex Therapeutics, TG Therapeutics, ...
southcarolinapublicradio10d
Pancreatic cancer research
Dr. Hawkins: So, there's a lot of new things being developed to try and detect and screen for pancreatic cancer. These are ...